Literature DB >> 34011972

Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding.

Kaituo Wang1, Robert Dagil2, Thomas Lavstsen2, Sandeep K Misra3, Charlotte B Spliid2,4, Yong Wang5, Tobias Gustavsson2,6, Daniel R Sandoval4, Elena Ethel Vidal-Calvo2,6, Swati Choudhary2, Mette Ø Agerbaek2, Kresten Lindorff-Larsen5, Morten A Nielsen2, Thor G Theander2, Joshua S Sharp3,7, Thomas Mandel Clausen4, Pontus Gourdon8,9, Ali Salanti10.   

Abstract

Placental malaria can have severe consequences for both mother and child and effective vaccines are lacking. Parasite-infected red blood cells sequester in the placenta through interaction between parasite-expressed protein VAR2CSA and the glycosaminoglycan chondroitin sulfate A (CS) abundantly present in the intervillous space. Here, we report cryo-EM structures of the VAR2CSA ectodomain at up to 3.1 Å resolution revealing an overall V-shaped architecture and a complex domain organization. Notably, the surface displays a single significantly electropositive patch, compatible with binding of negatively charged CS. Using molecular docking and molecular dynamics simulations as well as comparative hydroxyl radical protein foot-printing of VAR2CSA in complex with placental CS, we identify the CS-binding groove, intersecting with the positively charged patch of the central VAR2CSA structure. We identify distinctive conserved structural features upholding the macro-molecular domain complex and CS binding capacity of VAR2CSA as well as divergent elements possibly allowing immune escape at or near the CS binding site. These observations will support rational design of second-generation placental malaria vaccines.

Entities:  

Year:  2021        PMID: 34011972     DOI: 10.1038/s41467-021-23254-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  46 in total

Review 1.  A family affair: var genes, PfEMP1 binding, and malaria disease.

Authors:  Susan M Kraemer; Joseph D Smith
Journal:  Curr Opin Microbiol       Date:  2006-06-30       Impact factor: 7.934

2.  Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

Authors:  Ali Salanti; Thomas M Clausen; Mette Ø Agerbæk; Nader Al Nakouzi; Madeleine Dahlbäck; Htoo Zarni Oo; Sherry Lee; Tobias Gustavsson; Jamie R Rich; Bradley J Hedberg; Yang Mao; Line Barington; Marina A Pereira; Janine LoBello; Makoto Endo; Ladan Fazli; Jo Soden; Chris K Wang; Adam F Sander; Robert Dagil; Susan Thrane; Peter J Holst; Le Meng; Francesco Favero; Glen J Weiss; Morten A Nielsen; Jim Freeth; Torsten O Nielsen; Joseph Zaia; Nhan L Tran; Jeff Trent; John S Babcook; Thor G Theander; Poul H Sorensen; Mads Daugaard
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

3.  An analysis of malaria in pregnancy in Africa.

Authors:  B J Brabin
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.

Authors:  Sodiomon B Sirima; Laura Richert; Arnaud Chêne; Amadou T Konate; Cécilia Campion; Sébastien Dechavanne; Jean-Philippe Semblat; Nadine Benhamouda; Mathilde Bahuaud; Pierre Loulergue; Alphonse Ouédraogo; Issa Nébié; Moïse Kabore; Désiré Kargougou; Aïssata Barry; San Maurice Ouattara; Valérie Boilet; Florence Allais; Gwenaelle Roguet; Nicolas Havelange; Elvira Lopez-Perez; Alexis Kuppers; Eleine Konaté; Caroline Roussillon; Myriam Kanté; Linda Belarbi; Amidou Diarra; Noelie Henry; Issiaka Soulama; Amidou Ouédraogo; Helene Esperou; Odile Leroy; Frederic Batteux; Eric Tartour; Nicola K Viebig; Rodolphe Thiebaut; Odile Launay; Benoît Gamain
Journal:  Lancet Infect Dis       Date:  2020-02-04       Impact factor: 25.071

5.  Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta.

Authors:  R N Achur; M Valiyaveettil; A Alkhalil; C F Ockenhouse; D C Gowda
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

6.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes.

Authors:  D I Baruch; B L Pasloske; H B Singh; X Bi; X C Ma; M Feldman; T F Taraschi; R J Howard
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

7.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

8.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

9.  Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.

Authors:  Ali Salanti; Madeleine Dahlbäck; Louise Turner; Morten A Nielsen; Lea Barfod; Pamela Magistrado; Anja T R Jensen; Thomas Lavstsen; Michael F Ofori; Kevin Marsh; Lars Hviid; Thor G Theander
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

10.  Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production.

Authors:  Ron Dzikowski; Matthias Frank; Kirk Deitsch
Journal:  PLoS Pathog       Date:  2006-03-03       Impact factor: 6.823

View more
  3 in total

1.  Polymorphic Molecular Signatures in Variable Regions of the Plasmodium falciparum var2csa DBL3x Domain Are Associated with Virulence in Placental Malaria.

Authors:  Eldin Talundzic; Stephen Scott; Simon O Owino; David S Campo; Naomi W Lucchi; Venkatachalam Udhayakumar; Julie M Moore; David S Peterson
Journal:  Pathogens       Date:  2022-04-28

2.  A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.

Authors:  Justin Y A Doritchamou; Jonathan P Renn; Bethany Jenkins; Almahamoudou Mahamar; Alassane Dicko; Michal Fried; Patrick E Duffy
Journal:  Elife       Date:  2022-02-01       Impact factor: 8.713

3.  mSphere of Influence: Structural Insights into the Molecular Mechanism Underlying Placental Malaria.

Authors:  Maria Del Pilar Quintana
Journal:  mSphere       Date:  2021-05-28       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.